癌症仍然是全球死亡的主要原因之一,与常规化疗往往导致严重的副作用和有限的有效性。生物信息学和机器学习的最新进展,特别是深度学习,通过抗癌肽的预测和鉴定,为癌症治疗提供有希望的新途径。
■本研究旨在开发和评估利用二维卷积神经网络(2DCNN)的深度学习模型,以提高抗癌肽的预测准确性。解决了当前预测方法的复杂性和局限性。
从各种公共数据库和实验研究中编辑了具有注释的抗癌活性标记的肽序列的不同数据集。使用单热编码和其他物理化学性质对序列进行预处理和编码。使用该数据集对2DCNN模型进行了训练和优化,通过准确性等指标评估性能,精度,召回,F1分数,和受试者工作特征曲线下面积(AUC-ROC)。
■与现有方法相比,所提出的2DCNN模型实现了卓越的性能,准确率为0.87,准确率为0.85,召回率为0.89,F1评分为0.87,AUC-ROC值为0.91。这些结果表明模型在准确预测抗癌肽和捕获肽序列内复杂的空间模式方面的有效性。
■这些发现证明了深度学习的潜力,特别是2DCNN,推进抗癌肽的预测。该模型显著提高了预测精度,为识别用于癌症治疗的有效候选肽提供了有价值的工具。
■进一步的研究应该集中在扩展数据集,探索替代的深度学习架构,并通过实验研究验证模型的预测。努力还应旨在优化计算效率并将这些预测转化为临床应用。
UNASSIGNED: Cancer remains one of the leading causes of mortality globally, with conventional chemotherapy often resulting in severe side effects and limited effectiveness. Recent advancements in bioinformatics and machine learning, particularly deep learning, offer promising new avenues for cancer treatment through the prediction and identification of anticancer peptides.
UNASSIGNED: This study aimed to develop and evaluate a deep learning model utilizing a two-dimensional convolutional neural network (2D CNN) to enhance the prediction accuracy of anticancer peptides, addressing the complexities and limitations of current prediction methods.
UNASSIGNED: A diverse dataset of peptide sequences with annotated anticancer activity labels was compiled from various public databases and experimental studies. The sequences were preprocessed and encoded using one-hot encoding and additional physicochemical properties. The 2D CNN model was trained and optimized using this dataset, with performance evaluated through metrics such as accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC-ROC).
UNASSIGNED: The proposed 2D CNN model achieved superior performance compared to existing methods, with an accuracy of 0.87, precision of 0.85, recall of 0.89, F1-score of 0.87, and an AUC-ROC value of 0.91. These results indicate the model\'s effectiveness in accurately predicting anticancer peptides and capturing intricate spatial patterns within peptide sequences.
UNASSIGNED: The findings demonstrate the potential of deep learning, specifically 2D CNNs, in advancing the prediction of anticancer peptides. The proposed model significantly improves prediction accuracy, offering a valuable tool for identifying effective peptide candidates for cancer treatment.
UNASSIGNED: Further research should focus on expanding the dataset, exploring alternative deep learning architectures, and validating the model\'s predictions through experimental studies. Efforts should also aim at optimizing computational efficiency and translating these predictions into clinical applications.